Human Hexosaminidase A/HEXA antibody
HEXA (Hexosaminidase A), also designated beta-Hexosaminidase A, is responsible for the degradation of GM2 gangliosides, and a variety of other molecules containing terminal N-acetyl hexosamines, in the brain and other tissues. A mutation in the a subunit of hexosaminidase is the cause of Tay-Sachs disease (TSD), also known as GM2-gangliosidosis type I. TSD is a fatal autosomal recessive lysosomal storage disease of the central nervous system (CNS) caused by insufficient activity of the HEXA enzyme that results in a failure to process GM2 gangliosides. The accumulation of GM2 ganglioside in the absence of HEXA activity causes progressive destruction of the CNS.
Product Specifications
Product Name Alternative
Beta-hexosaminidase subunit alpha, TSD, hexosaminidase A
Host
Mouse
Antigen Species
Human
Reactivity
Human
Immunogen
Recombinant human HEXA (89-529aa) purified from E. coli
Clonality
Monoclonal
Isotype
IgG2a λ
Clone
AT20F1
Conjugation
Unconjugated
Applications
ELISA, WB, FACS
Purification Method
By protein-A affinity chromatography
Concentration
1 mg/mL (determined by BCA assay)
Additionnal Information
References & Citations
Storage Conditions
Can be stored at 2°C to 8°C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% glycerol
Applications Notes
Scientific Category
Signal Transduction
NCBI Accession Number
NP_000511.1
Uniprot Accession Number
P06865
WB Description
FACS Description
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items